ArticleActa orthopaedica2026
Association of treatment method with mortality and functional outcome in patients with displaced femoral neck fracture: a cohort study of 60-69-year-old patients from the Swedish Hip Fracture Register.
Article in Acta orthopaedica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeOptimal treatment for displaced femoral neck fractures (FNF) in patients aged 60-69 years remains controversial. We aimed to compare mortality and short-term clinical outcomes after total hip arthroplasty (THA), hemiarthroplasty (HA), or internal fixation (IF) after displaced FNF.
methodsWe included 3,325 patients aged 60-69 years with displaced FNF recorded in the Swedish Hip Fracture Register. 1-year mortality and 4-month functional outcomes (maintenance of independent living and outdoor walking ability) were analyzed. Analyses were stratified by American Society of Anesthesiologists (ASA) class (I-II vs III-IV).
resultsOverall, 1-year mortality was 8.3%. Adjusted analyses showed higher 1-year mortality after HA (odds ratio [OR] 2.5, 95% confidence interval [CI] 1.7-3.6) and IF (OR 2.3, CI 1.6-3.3) compared with THA. Survival analyses demonstrated lower survival probabilities after HA and IF compared with THA in ASA III-IV but not in ASA I-II patients. THA was associated with higher odds of maintaining independent living (IF: OR 0.40, CI 0.20-0.86; HA: OR 0.09, CI 0.04-0.17) and maintaining outdoor walking ability (IF: OR 0.35, CI 0.24-0.50; HA: OR 0.26, CI 0.16-0.43) in ASA I-II patients. In ASA III-IV patients, estimates were closer to unity.
conclusionTHA was associated with lower mortality in ASA III-IV and better functional outcomes in ASA I-II.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.